Tsuchimoto Kim R Insider Trades

Insider Trading History

Track insider trading activity for Tsuchimoto Kim R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monopar Therapeutics
Monopar Therapeutics MNPR
Director
Holding Value $174k 2,924 shares
Last Trade
Dec 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 2,924 shares
$75.94
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Director
Holding Value $1.22M 20,390 shares
Last Trade
Jul 14, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$389k 8,904 shares
$43.73
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Director
Holding Value $685k 11,486 shares
Last Trade
Jul 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$356k 8,904 shares
$40.00
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Director
Holding Value $0 0 shares
Last Trade
Jul 14, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$206k 4,704 shares
$43.73
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Director
Holding Value $677k 11,365 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$360k 11,365 shares
$31.70
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $3.42M 57,429 shares
Last Trade
Jun 30, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.9k 2,998 shares
$3.65
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $3.6M 60,427 shares
Last Trade
Jun 30, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$36.3k 9,957 shares
$3.65
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $4.44M 74,412 shares
Last Trade
Jun 30, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$36.3k 9,957 shares
$3.65
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $3.01M 50,470 shares
Last Trade
Mar 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.9k 4,082 shares
$3.41
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $3.25M 54,552 shares
Last Trade
Mar 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.9k 9,956 shares
$3.41
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $5.03M 84,369 shares
Last Trade
Mar 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.9k 9,956 shares
$3.41
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $2.66M 44,596 shares
Last Trade
Jan 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$859 505 shares
$1.70
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $2.69M 45,101 shares
Last Trade
Jan 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.09k 1,231 shares
$1.70
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $5.62M 94,325 shares
Last Trade
Jan 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.09k 1,231 shares
$1.70
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $2.86M 47,943 shares
Last Trade
Dec 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.9k 9,957 shares
$1.70
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $2.62M 43,870 shares
Last Trade
Dec 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.92k 4,073 shares
$1.70
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $5.7M 95,556 shares
Last Trade
Dec 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.9k 9,957 shares
$1.70
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $2.26M 37,986 shares
Last Trade
Sep 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.7k 3,444 shares
$3.10
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $2.47M 41,430 shares
Last Trade
Sep 30, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30.9k 9,956 shares
$3.10
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Financial Officer
Holding Value $6.29M 105,513 shares
Last Trade
Sep 30, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30.9k 9,956 shares
$3.10
$59.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up